<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-31" modified="2020-10-07" version="143">
<accession>Q53EL6</accession>
<accession>B2RCV4</accession>
<accession>B5ME91</accession>
<accession>O15501</accession>
<accession>Q5VZS6</accession>
<accession>Q6PJI5</accession>
<accession>Q8TAR5</accession>
<accession>Q99834</accession>
<name>PDCD4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Programmed cell death protein 4</fullName>
</recommendedName>
<alternativeName>
<fullName>Neoplastic transformation inhibitor protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear antigen H731-like</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein 197/15a</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PDCD4</name>
<name type="synonym">H731</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Res. Commun. Biochem. Cell Mol. Biol." volume="1" first="109" last="120">
<title>Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle.</title>
<authorList>
<person name="Matsuhashi S."/>
<person name="Yoshinaga H."/>
<person name="Yatsuki H."/>
<person name="Tsugita A."/>
<person name="Hori K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-36</scope>
<source>
<tissue>Glial tumor</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="J. Immunol." volume="161" first="3493" last="3500">
<title>Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.</title>
<authorList>
<person name="Azzoni L."/>
<person name="Zatsepina O."/>
<person name="Abebe B."/>
<person name="Bennett I.M."/>
<person name="Kanakaraj P."/>
<person name="Perussia B."/>
</authorList>
<dbReference type="PubMed" id="9759869"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INDUCTION</scope>
<scope>VARIANT VAL-36</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT VAL-36</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-36</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS VAL-36 AND TYR-48</scope>
<source>
<tissue>Brain</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Pathol. Int." volume="49" first="1067" last="1077">
<title>Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody.</title>
<authorList>
<person name="Yoshinaga H."/>
<person name="Matsuhashi S."/>
<person name="Fujiyama C."/>
<person name="Masaki Z."/>
</authorList>
<dbReference type="PubMed" id="10632927"/>
<dbReference type="DOI" id="10.1046/j.1440-1827.1999.00995.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Pathol." volume="200" first="640" last="646">
<title>Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.</title>
<authorList>
<person name="Chen Y."/>
<person name="Knosel T."/>
<person name="Kristiansen G."/>
<person name="Pietas A."/>
<person name="Garber M.E."/>
<person name="Matsuhashi S."/>
<person name="Ozaki I."/>
<person name="Petersen I."/>
</authorList>
<dbReference type="PubMed" id="12898601"/>
<dbReference type="DOI" id="10.1002/path.1378"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="11282" last="11286">
<title>Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.</title>
<authorList>
<person name="Palamarchuk A."/>
<person name="Efanov A."/>
<person name="Maximov V."/>
<person name="Aqeilan R.I."/>
<person name="Croce C.M."/>
<person name="Pekarsky Y."/>
</authorList>
<dbReference type="PubMed" id="16357133"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-3469"/>
</citation>
<scope>PHOSPHORYLATION AT SER-67 AND SER-457 BY PKB</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-67 AND SER-457</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-152</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1297" last="1306">
<title>Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.</title>
<authorList>
<person name="Yang H.-S."/>
<person name="Matthews C.P."/>
<person name="Clair T."/>
<person name="Wang Q."/>
<person name="Baker A.R."/>
<person name="Li C.-C."/>
<person name="Tan T.-H."/>
<person name="Colburn N.H."/>
</authorList>
<dbReference type="PubMed" id="16449643"/>
<dbReference type="DOI" id="10.1128/mcb.26.4.1297-1306.2006"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Science" volume="314" first="467" last="471">
<title>S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.</title>
<authorList>
<person name="Dorrello N.V."/>
<person name="Peschiaroli A."/>
<person name="Guardavaccaro D."/>
<person name="Colburn N.H."/>
<person name="Sherman N.E."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="17053147"/>
<dbReference type="DOI" id="10.1126/science.1130276"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-67 BY RPS6KB1</scope>
<scope>PHOSPHODEGRON MOTIF</scope>
<scope>INTERACTION WITH BTRC AND FBXW11</scope>
<scope>UBIQUITINATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-67; SER-71 AND SER-76</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-80 AND SER-94</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-94 AND SER-457</scope>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-36</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-76; SER-78; SER-313; SER-317 AND SER-457</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-68; SER-71; SER-76; SER-78; SER-313 AND SER-317</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="submission" date="2007-04" db="PDB data bank">
<title>Solution structure of the MA3 domain of human programmed cell death 4.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 320-450</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3274" last="3279">
<title>PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.</title>
<authorList>
<person name="Suzuki C."/>
<person name="Garces R.G."/>
<person name="Edmonds K.A."/>
<person name="Hiller S."/>
<person name="Hyberts S.G."/>
<person name="Marintchev A."/>
<person name="Wagner G."/>
</authorList>
<dbReference type="PubMed" id="18296639"/>
<dbReference type="DOI" id="10.1073/pnas.0712235105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 157-320</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH EIF4A</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="274" last="285">
<title>Structural basis for translational inhibition by the tumour suppressor Pdcd4.</title>
<authorList>
<person name="Loh P.G."/>
<person name="Yang H.S."/>
<person name="Walsh M.A."/>
<person name="Wang Q."/>
<person name="Wang X."/>
<person name="Cheng Z."/>
<person name="Liu D."/>
<person name="Song H."/>
</authorList>
<dbReference type="PubMed" id="19153607"/>
<dbReference type="DOI" id="10.1038/emboj.2008.278"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 157-469</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EIF4A1 AND EIF4G</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF GLU-174; GLU-210; GLU-249; LEU-252; ASP-253; PRO-255; HIS-358; ASP-414; ASP-418 AND PRO-420</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="3148" last="3153">
<title>Crystal structure of the eIF4A-PDCD4 complex.</title>
<authorList>
<person name="Chang J.H."/>
<person name="Cho Y.H."/>
<person name="Sohn S.Y."/>
<person name="Choi J.M."/>
<person name="Kim A."/>
<person name="Kim Y.C."/>
<person name="Jang S.K."/>
<person name="Cho Y."/>
</authorList>
<dbReference type="PubMed" id="19204291"/>
<dbReference type="DOI" id="10.1073/pnas.0808275106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 163-469 IN COMPLEX WITH EIF4A1</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ASP-253; MET-333; GLU-337; LEU-340; PHE-359 AND HIS-361</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ARG-120</scope>
</reference>
<comment type="function">
<text evidence="13 22 23 25 26 27 28">Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="13 25 26 27 28">Interacts (via MI domains) with EIF4A2 (By similarity). Interacts (via MI domains) with EIF4A1 (via N-terminal domain). Heterotrimer with EIF4A1; one molecule of PDCD4 binds two molecules of EIF4A1. Interacts with EIF4G1. May form a complex with EIF4A1 and EIF4G1. The interaction between PDCD4 and EIF4A1 interferes with the interaction between EIF4A1 and EIF4G. When phosphorylated, interacts with BTRC and FBXW11.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-1222467">
<id>P02649</id>
<label>APOE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-73449">
<id>P60842</id>
<label>EIF4A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-73473">
<id>Q14240</id>
<label>EIF4A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-10232522">
<id>Q14240-2</id>
<label>EIF4A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-299104">
<id>P38919</id>
<label>EIF4A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-2010251">
<id>P49810</id>
<label>PSEN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
</interactant>
<interactant intactId="EBI-351850">
<id>P62277</id>
<label>RPS13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
</subcellularLocation>
<text evidence="22">Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q53EL6-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q53EL6-2</id>
<name>2</name>
<sequence type="described" ref="VSP_045622"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="18 19 23">Up-regulated in proliferative cells. Highly expressed in epithelial cells of the mammary gland. Reduced expression in lung cancer and colon carcinoma.</text>
</comment>
<comment type="induction">
<text evidence="29">IL2/interleukin-2 stimulation inhibits expression, while IL12/interleukin-12 increases expression.</text>
</comment>
<comment type="domain">
<text evidence="26 28">Binds EIF4A1 via both MI domains.</text>
</comment>
<comment type="PTM">
<text evidence="25">Polyubiquitinated, leading to its proteasomal degradation. Rapidly degraded in response to mitogens. Phosphorylation of the phosphodegron promotes interaction with BTRC and proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="22 25">Phosphorylated at Ser-67 by RPS6KB1 in response to mitogens; phosphorylation promotes proteasomal degradation of PDCD4.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the PDCD4 family.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAB42218" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH15036" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PDCD4ID41675ch10q24.html"/>
</comment>
<dbReference type="EMBL" id="U83908">
<property type="protein sequence ID" value="AAB42218.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U96628">
<property type="protein sequence ID" value="AAB67706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315295">
<property type="protein sequence ID" value="BAG37701.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223623">
<property type="protein sequence ID" value="BAD97343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158163">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL136368">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015036">
<property type="protein sequence ID" value="AAH15036.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC026104">
<property type="protein sequence ID" value="AAH26104.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC031049">
<property type="protein sequence ID" value="AAH31049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44478.1">
<molecule id="Q53EL6-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7567.1">
<molecule id="Q53EL6-1"/>
</dbReference>
<dbReference type="PIR" id="JC5193">
<property type="entry name" value="JC5193"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055271.2">
<molecule id="Q53EL6-1"/>
<property type="nucleotide sequence ID" value="NM_014456.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_663314.1">
<molecule id="Q53EL6-2"/>
<property type="nucleotide sequence ID" value="NM_145341.3"/>
</dbReference>
<dbReference type="PDB" id="2GGF">
<property type="method" value="NMR"/>
<property type="chains" value="A=327-450"/>
</dbReference>
<dbReference type="PDB" id="2KZT">
<property type="method" value="NMR"/>
<property type="chains" value="A=157-318"/>
</dbReference>
<dbReference type="PDB" id="2RG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=157-320"/>
</dbReference>
<dbReference type="PDB" id="2ZU6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B/E=163-469"/>
</dbReference>
<dbReference type="PDB" id="3EIJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=157-469"/>
</dbReference>
<dbReference type="PDBsum" id="2GGF"/>
<dbReference type="PDBsum" id="2KZT"/>
<dbReference type="PDBsum" id="2RG8"/>
<dbReference type="PDBsum" id="2ZU6"/>
<dbReference type="PDBsum" id="3EIJ"/>
<dbReference type="BMRB" id="Q53EL6"/>
<dbReference type="SMR" id="Q53EL6"/>
<dbReference type="BioGRID" id="118098">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="CORUM" id="Q53EL6"/>
<dbReference type="DIP" id="DIP-29756N"/>
<dbReference type="ELM" id="Q53EL6"/>
<dbReference type="IntAct" id="Q53EL6">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000280154"/>
<dbReference type="BindingDB" id="Q53EL6"/>
<dbReference type="ChEMBL" id="CHEMBL1781868"/>
<dbReference type="DrugCentral" id="Q53EL6"/>
<dbReference type="CarbonylDB" id="Q53EL6"/>
<dbReference type="iPTMnet" id="Q53EL6"/>
<dbReference type="MetOSite" id="Q53EL6"/>
<dbReference type="PhosphoSitePlus" id="Q53EL6"/>
<dbReference type="SwissPalm" id="Q53EL6"/>
<dbReference type="BioMuta" id="PDCD4"/>
<dbReference type="DMDM" id="317373317"/>
<dbReference type="EPD" id="Q53EL6"/>
<dbReference type="jPOST" id="Q53EL6"/>
<dbReference type="MassIVE" id="Q53EL6"/>
<dbReference type="MaxQB" id="Q53EL6"/>
<dbReference type="PaxDb" id="Q53EL6"/>
<dbReference type="PeptideAtlas" id="Q53EL6"/>
<dbReference type="PRIDE" id="Q53EL6"/>
<dbReference type="ProteomicsDB" id="6218"/>
<dbReference type="ProteomicsDB" id="62437">
<molecule id="Q53EL6-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="616">
<property type="antibodies" value="792 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="27250"/>
<dbReference type="Ensembl" id="ENST00000280154">
<molecule id="Q53EL6-1"/>
<property type="protein sequence ID" value="ENSP00000280154"/>
<property type="gene ID" value="ENSG00000150593"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393104">
<molecule id="Q53EL6-2"/>
<property type="protein sequence ID" value="ENSP00000376816"/>
<property type="gene ID" value="ENSG00000150593"/>
</dbReference>
<dbReference type="GeneID" id="27250"/>
<dbReference type="KEGG" id="hsa:27250"/>
<dbReference type="UCSC" id="uc001kzg.4">
<molecule id="Q53EL6-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="27250"/>
<dbReference type="DisGeNET" id="27250"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000150593.15"/>
<dbReference type="GeneCards" id="PDCD4"/>
<dbReference type="HGNC" id="HGNC:8763">
<property type="gene designation" value="PDCD4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000150593">
<property type="expression patterns" value="Tissue enhanced (pancreas)"/>
</dbReference>
<dbReference type="MIM" id="608610">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q53EL6"/>
<dbReference type="OpenTargets" id="ENSG00000150593"/>
<dbReference type="PharmGKB" id="PA33113"/>
<dbReference type="eggNOG" id="KOG0403">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000015948"/>
<dbReference type="HOGENOM" id="CLU_025354_1_0_1"/>
<dbReference type="InParanoid" id="Q53EL6"/>
<dbReference type="KO" id="K16865"/>
<dbReference type="OMA" id="NLGPMRS"/>
<dbReference type="OrthoDB" id="434771at2759"/>
<dbReference type="PhylomeDB" id="Q53EL6"/>
<dbReference type="TreeFam" id="TF323207"/>
<dbReference type="PathwayCommons" id="Q53EL6"/>
<dbReference type="Reactome" id="R-HSA-8950505">
<property type="pathway name" value="Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q53EL6"/>
<dbReference type="BioGRID-ORCS" id="27250">
<property type="hits" value="4 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PDCD4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q53EL6"/>
<dbReference type="GeneWiki" id="PDCD4"/>
<dbReference type="GenomeRNAi" id="27250"/>
<dbReference type="Pharos" id="Q53EL6">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q53EL6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="Q53EL6">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000150593">
<property type="expression patterns" value="Expressed in body of pancreas and 243 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q53EL6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q53EL6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030509">
<property type="term" value="P:BMP signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060940">
<property type="term" value="P:epithelial to mesenchymal transition involved in cardiac fibroblast development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035722">
<property type="term" value="P:interleukin-12-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045786">
<property type="term" value="P:negative regulation of cell cycle"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900016">
<property type="term" value="P:negative regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043508">
<property type="term" value="P:negative regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904761">
<property type="term" value="P:negative regulation of myofibroblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905064">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904706">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905461">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.180">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003891">
<property type="entry name" value="Initiation_fac_eIF4g_MI"/>
</dbReference>
<dbReference type="InterPro" id="IPR016021">
<property type="entry name" value="MIF4-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR039778">
<property type="entry name" value="PDCD4"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12626">
<property type="entry name" value="PTHR12626"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02847">
<property type="entry name" value="MA3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00544">
<property type="entry name" value="MA3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51366">
<property type="entry name" value="MI"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Programmed cell death protein 4" id="PRO_0000256519">
<location>
<begin position="1"/>
<end position="469"/>
</location>
</feature>
<feature type="domain" description="MI 1" evidence="17">
<location>
<begin position="163"/>
<end position="284"/>
</location>
</feature>
<feature type="domain" description="MI 2" evidence="17">
<location>
<begin position="326"/>
<end position="449"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="16">
<location>
<begin position="58"/>
<end position="64"/>
</location>
</feature>
<feature type="short sequence motif" description="Phosphodegron">
<location>
<begin position="70"/>
<end position="76"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="16">
<location>
<begin position="241"/>
<end position="250"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="9">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB and RPS6KB1" evidence="12 22 25">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 11 12">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 11 12">
<location>
<position position="78"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="80"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="94"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12">
<location>
<position position="313"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB" evidence="4 6 7 9 10 11 22">
<location>
<position position="457"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_045622" evidence="32">
<original>MDVENEQILNVNPAD</original>
<variation>MTKY</variation>
<location>
<begin position="1"/>
<end position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7081726." id="VAR_028901" evidence="9 20 21 29 30 31">
<original>I</original>
<variation>V</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11548765." id="VAR_028902" evidence="21">
<original>S</original>
<variation>Y</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036375" evidence="24">
<original>G</original>
<variation>R</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Reduces interaction with BTRC. Abolishes phosphorylation by PKB; when associated with A-457." evidence="22 25">
<original>S</original>
<variation>A</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with BTRC. Strongly reduced ubiquitination." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with BTRC. Strongly reduced ubiquitination." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity." evidence="27">
<original>E</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="27">
<original>E</original>
<variation>A</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with EIF4A1." evidence="27">
<original>E</original>
<variation>A</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="27">
<original>L</original>
<variation>A</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity." evidence="27 28">
<original>D</original>
<variation>A</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="27">
<original>P</original>
<variation>A</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-340." evidence="28">
<original>M</original>
<variation>A</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation." evidence="28">
<original>E</original>
<variation>A</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-333." evidence="28">
<original>L</original>
<variation>A</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1." evidence="27">
<original>H</original>
<variation>A</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation." evidence="28">
<original>F</original>
<variation>A</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation." evidence="28">
<original>H</original>
<variation>A</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="27">
<original>D</original>
<variation>A</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="27">
<original>D</original>
<variation>A</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="27">
<original>P</original>
<variation>A</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site, and loss of nuclear accumulation. Abolishes phosphorylation by PKB; when associated with A-67." evidence="22">
<original>S</original>
<variation>A</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB42218." ref="1" evidence="33">
<original>D</original>
<variation>E</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB67706." ref="2" evidence="33">
<original>R</original>
<variation>G</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB67706." ref="2" evidence="33">
<original>V</original>
<variation>G</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB42218." ref="1" evidence="33">
<original>S</original>
<variation>T</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB67706." ref="2" evidence="33">
<original>L</original>
<variation>F</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG37701." ref="3" evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG37701." ref="3" evidence="33">
<original>V</original>
<variation>A</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB67706." ref="2" evidence="33">
<original>S</original>
<variation>W</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="161"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="181"/>
<end position="191"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="195"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="199"/>
<end position="209"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="213"/>
<end position="226"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="233"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="257"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="289"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="308"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="324"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="344"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="357"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="360"/>
<end position="372"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="378"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="398"/>
<end position="418"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="422"/>
<end position="435"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="441"/>
<end position="445"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KZT"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RG8"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ZU6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15144186"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61823"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JID1"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255"/>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00698"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10632927"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12898601"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16357133"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16449643"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17053147"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18296639"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19153607"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19204291"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9759869"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source ref="1"/>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<sequence length="469" mass="51735" checksum="2CAE1D2055491177" modified="2011-01-11" version="2">MDVENEQILNVNPADPDNLSDSLFSGDEENAGTEEIKNEINGNWISASSINEARINAKAKRRLRKNSSRDSGRGDSVSDSGSDALRSGLTVPTSPKGRLLDRRSRSGKGRGLPKKGGAGGKGVWGTPGQVYDVEEVDVKDPNYDDDQENCVYETVVLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGVPVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKEIDMLLKEYLLSGDISEAEHCLKELEVPHFHHELVYEAIIMVLESTGESTFKMILDLLKSLWKSSTITVDQMKRGYERIYNEIPDINLDVPHSYSVLERFVEECFQAGIISKQLRDLCPSRGRKRFVSEGDGGRLKPESY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

